In the structure of prescribing medications for CKD (eGFR < 60 mL), SGLT2ins (alone or in combination) were most commonly prescribed, followed equally by GLP-1 RAs (alone or in combination) and the combination of SGLT2ins and GLP-1 RAs, while basal insulin was still highly represented. Here, GLP1R is linked to chronic kidney disease.